Amylyx Pharmaceuticals Inc (AMLX)
1.72
+0.04
(+2.38%)
USD |
NASDAQ |
May 31, 16:00
1.72
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Market Cap: 116.97M for May 31, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 31, 2024 | 116.97M |
| May 30, 2024 | 114.25M |
| May 29, 2024 | 113.57M |
| May 28, 2024 | 116.29M |
| May 24, 2024 | 117.65M |
| May 23, 2024 | 121.05M |
| May 22, 2024 | 124.45M |
| May 21, 2024 | 122.41M |
| May 20, 2024 | 125.13M |
| May 17, 2024 | 124.45M |
| May 16, 2024 | 124.45M |
| May 15, 2024 | 123.77M |
| May 14, 2024 | 127.17M |
| May 13, 2024 | 123.77M |
| May 10, 2024 | 119.35M |
| May 09, 2024 | 128.53M |
| May 08, 2024 | 131.25M |
| May 07, 2024 | 133.97M |
| May 06, 2024 | 135.33M |
| May 03, 2024 | 138.05M |
| May 02, 2024 | 136.01M |
| May 01, 2024 | 131.25M |
| April 30, 2024 | 123.09M |
| April 29, 2024 | 129.21M |
| April 26, 2024 | 119.69M |
| Date | Value |
|---|---|
| April 25, 2024 | 121.05M |
| April 24, 2024 | 127.85M |
| April 23, 2024 | 132.61M |
| April 22, 2024 | 134.65M |
| April 19, 2024 | 127.17M |
| April 18, 2024 | 134.65M |
| April 17, 2024 | 136.01M |
| April 16, 2024 | 136.69M |
| April 15, 2024 | 140.77M |
| April 12, 2024 | 142.81M |
| April 11, 2024 | 155.66M |
| April 10, 2024 | 167.22M |
| April 09, 2024 | 181.49M |
| April 08, 2024 | 182.85M |
| April 05, 2024 | 178.10M |
| April 04, 2024 | 177.42M |
| April 03, 2024 | 178.78M |
| April 02, 2024 | 178.10M |
| April 01, 2024 | 184.21M |
| March 28, 2024 | 192.50M |
| March 27, 2024 | 195.21M |
| March 26, 2024 | 185.72M |
| March 25, 2024 | 183.69M |
| March 22, 2024 | 185.72M |
| March 21, 2024 | 194.53M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
113.57M
Minimum
May 29 2024
2.722B
Maximum
Jan 27 2023
1.366B
Average
1.330B
Median
Market Cap Benchmarks
| iRhythm Technologies Inc | 2.744B |
| Cassava Sciences Inc | 1.058B |
| Bristol-Myers Squibb Co | 83.29B |
| Moderna Inc | 54.63B |
| ACADIA Pharmaceuticals Inc | 2.492B |
Market Cap Related Metrics
| PS Ratio | 0.2996 |
| Price to Book Value | 0.3605 |
| Price to Free Cash Flow | 7.720 |
| Price | 1.72 |
| Earnings Yield | -62.21% |